RI
FLGT icon

RTW Investments’s Fulgent Genetics FLGT Stock Holding History

RTW Investments’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,289,000
Closed -$20.5M – 92
2026
Q1 		$20.5M Buy
1,289,000
+583,973
+83% +$12.7M 0.2% 61
2025
Q4 		$18.5M Buy
+705,027
New +$18.3M 0.19% 61
2020
Q3 		– Sell
-75,000
Closed -$1.2M – 92
2020
Q2 		$1.2M Hold
75,000
– – 0.03% 72
2020
Q1 		$807K Hold
75,000
– – 0.03% 61
2019
Q4 		$968K Buy
+75,000
New +$891K 0.04% 58

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments's FLGT Position: Q2 2026 in Review

RTW Investments sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 1,289,000 shares — an estimated $20.5M sold.

RTW Investments first reported a position in FLGT in Q4 2019 and held it in 5 quarters. The position peaked at $20.5M in Q1 2026. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • RTW Investments reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • RTW Investments sold 1,289,000 Fulgent Genetics shares in Q2 2026, an estimated $20.5M.
  • RTW Investments first reported a position in Fulgent Genetics in Q4 2019 and held it in 5 quarters.
  • RTW Investments's Fulgent Genetics position peaked at $20.5M in Q1 2026.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.